![]() ![]() Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. is the provider of commercial laboratory services. ![]() However, with a sluggish industry rank (among the bottom 5%) and a Zacks Rank #3, it is hard to get too excited about this company overall.Quest Diagnostics Historical Annual Stock Price Data Quest Diagnostics is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. That is why we are looking for in-line performance from the company in the near term. QUEST DIAGNOSTICS STOCK FULLThe current quarter has seen four estimates go higher in the past sixty days compared to one lower, while the full year estimate has seen six upward and two downward revisions in the same time period.Īs a result, the current quarter consensus estimate has risen by 17.1% in the past two months, while the full year estimate has increased 3.9%.Įven though Quest Diagnostics has a better estimates trend, the stock has just a Zacks Rank #3 (Hold). Meanwhile, the company’s recent earnings estimates have been mixed at best. (You can read more about the Zacks Style Scores here >) This gives DGX a Zacks VGM score-or its overarching fundamental grade-of B. In particular, it is worth noting that the company has a Growth grade of D and a Momentum score of D. Though Quest Diagnostics might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. Clearly, DGX is a solid choice on the value front from multiple angles. This makes Quest Diagnostics a solid choice for value investors, and some of its other key metrics make this pretty clear too.įor example, its P/CF ratio (another great indicator of value) comes in at 7.44, which is better than the industry average of 10.37. In aggregate, Quest Diagnostics currently has a Zacks Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. If anything, DGX is in the lower end of its range in the time period from a P/S metric, suggesting some level of undervalued trading-at least compared to historical norms. On this front, Quest Diagnostics has a trailing twelve months PE ratio of 9.56, as you can see in the chart below: The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past b) how it compares to the average for the industry/sector and c) how it compares to the market as a whole. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. Let’s put Quest Diagnostics Incorporated DGX stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks: PE RatioĪ key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? Value investing is easily one of the most popular ways to find great stocks in any market environment. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |